TNXP
TNXP
NASDAQ · Biotechnology

Tonix Pharmaceuticals Holdin

$9.74
-0.16 (-1.62%)
As of Sep 29, 2:35 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +318.3% upside
Low Target $28.14
Average Target $40.74
High Target $50.62
Current Price $9.74
Current
$9.74
Target
$40.74
$28.14 $40.74 avg $50.62
Scenario Analysis
Bear Case
$28.14
188.9%
Low target
Base Case
$40.74
+318.3%
Avg target
Bull Case
$50.62
+419.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$25.69
-62.1% from high
52-Week Low
$9.40
+3.6% from low
Target vs 52W High
$40.74
+58.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%